Diagnosis and treatment of pulmonary alveolar microlithiasis

EMİRALİOĞLU N., Beken B., ÖZCAN H. N., Yalcin E., Dogru D., Ozcelik U., ...Daha Fazla

PEDIATRICS INTERNATIONAL, cilt.58, sa.8, ss.805-807, 2016 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 58 Sayı: 8
  • Basım Tarihi: 2016
  • Doi Numarası: 10.1111/ped.13032
  • Dergi Adı: PEDIATRICS INTERNATIONAL
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.805-807
  • Anahtar Kelimeler: diagnostic imaging, disodium etidronate, pulmonary alveolar microlithiasis
  • Hacettepe Üniversitesi Adresli: Evet

Özet

Pulmonary alveolar microlithiasis (PAM) is a rare genetic disease caused by mutations in sodium-phosphate co-transporter (SLC34A2), which encodes a type 2b sodium phosphate co-transporter. Disease is characterized byintra-alveolar microlith formation of phosphate. Turkey has a high prevalence of PAM. Herein, we report the clinical and radiological findings of three patients diagnosed with PAM and treated with disodium etidronate.